전남대학교 중앙도서관

Co-producing Human and Animal Experimental Subjects: Exploring the Views of UK COVID-19 Vaccine Trial Participants on Animal Testing.

학술저널

issue: Science, technology & human values [Sci Technol Human Values] 2023 Jul; Vol. 48 (4), pp. 909-937. Date of Electronic Publication: 2021 Nov 15.
Author: Vanderslott S; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.; Oxford Martin School, University of Oxford, United Kingdom.
Palmer A; School of Geography and the Environment, Oxford University Centre for the Environment, University of Oxford, United Kingdom.
Thomas T; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Greenhough B; School of Geography and the Environment, Oxford University Centre for the Environment, University of Oxford, United Kingdom.
Stuart A; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Henry JA; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.; Medical Sciences Division, University of Oxford Medical School, University of Oxford, United Kingdom.
English M; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.; Medical Sciences Division, University of Oxford Medical School, University of Oxford, United Kingdom.
Naude RW; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.; Medical Sciences Division, University of Oxford Medical School, University of Oxford, United Kingdom.
Patrick-Smith M; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.; Medical Sciences Division, University of Oxford Medical School, University of Oxford, United Kingdom.
Douglas N; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Moore M; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Hodgson SH; Jenner Institute, Nuffield Department of Medicine, University of Oxford, United Kingdom.
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom.
DB Label: Database : MEDLINE

원문보기: Full Text (Sage HSS) 등재 - SCOPUS 조회 - Impact Factor (JCR) 원문복사신청 - RISS

Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial.

학술저널

issue: Clinical and translational science [Clin Transl Sci] 2022 Feb; Vol. 15 (2), pp. 524-534. Date of Electronic Publication: 2021 Oct 20.
Author: Hodgson SH; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Oxford, UK.
Iveson P; The University of Oxford Clinical Medical School, University of Oxford, Oxford, UK.
Larwood J; The University of Oxford Clinical Medical School, University of Oxford, Oxford, UK.
Roche S; The University of Oxford Clinical Medical School, University of Oxford, Oxford, UK.
Morrison H; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Oxford, UK.
Cosgrove C; Vaccine Institute, St George's University of London, London, UK.
Galiza E; Vaccine Institute, St George's University of London, London, UK.
Ikram S; Vaccine Institute, St George's University of London, London, UK.
Lemm NM; Clinical Research Facility, Imperial College London, London, UK.
Mehdipour S; Clinical Research Facility, Imperial College London, London, UK.
Owens D; NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Pacurar M; NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Schumacher M; Clinical Research Facility, Imperial College London, London, UK.
Shaw RH; Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Faust SN; NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Heath PT; Vaccine Institute, St George's University of London, London, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Pollock KM; Clinical Research Facility, Imperial College London, London, UK.
Lazarus R; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
DB Label: Database : MEDLINE

원문보기: Full Text (원문보기) Full Text (원문보기) Open Access (PubMed Central) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

학술저널

issue: Lancet (London, England) [Lancet] 2021 Dec 19; Vol. 396 (10267), pp. 1979-1993. Date of Electronic Publication: 2020 Nov 19.
Author: Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk.
Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK.
Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK.
Flaxman AL; The Jenner Institute, University of Oxford, Oxford, UK.
Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK.
Owens DR; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Angus B; The Jenner Institute, University of Oxford, Oxford, UK.
Babbage G; The Jenner Institute, University of Oxford, Oxford, UK.
Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK.
Berry L; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK.
Cathie K; Paediatric Medicine, University of Southampton, Southampton, UK.
Chappell H; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Charlton S; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
Cicconi P; The Jenner Institute, University of Oxford, Oxford, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Colin-Jones R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Fedosyuk S; The Jenner Institute, University of Oxford, Oxford, UK.
Fuskova M; The Jenner Institute, University of Oxford, Oxford, UK.
Gbesemete D; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Green C; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.
Hallis B; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
Hou MM; The Jenner Institute, University of Oxford, Oxford, UK.
Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK.
Joe CCD; The Jenner Institute, University of Oxford, Oxford, UK.
Kelly EJ; AstraZeneca BioPharmaceuticals Research and Development, Washington, DC, USA.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lawrie AM; The Jenner Institute, University of Oxford, Oxford, UK.
Lelliott A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lwin MN; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Makinson R; The Jenner Institute, University of Oxford, Oxford, UK.
Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Munro APS; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Pacurar M; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Rand J; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Rawlinson T; The Jenner Institute, University of Oxford, Oxford, UK.
Rhead S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Robinson H; Nuffield Department of Medicine, and Oxford Centre for Clinical Tropical Medicine and Global Health, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Ritchie AJ; The Jenner Institute, University of Oxford, Oxford, UK.
Ross-Russell AL; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Saich S; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Smith CC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
Tarrant R; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.
Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, UK.
Thomas KM; National Infection Service, Public Health England, Porton Down, Salisbury, UK.
Villafana TL; AstraZeneca BioPharmaceuticals Research and Development, Bethesda, MA, USA.
Warren SC; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK.
Watson MEE; The Jenner Institute, University of Oxford, Oxford, UK.
Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Lambe T; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.

학술저널

issue: Nature communications [Nat Commun] 2021 Oct 06; Vol. 12 (1), pp. 5861. Date of Electronic Publication: 2021 Oct 06.
Author: Clemens SAC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Institute of Global Health, University of Siena, Siena, Italy.
Folegatti PM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Weckx LY; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.
Ratcliff J; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
De Almeida Mendes AV; Escola Bahiana de Medicina e Saúde Pública, Brazil and ID'OR, Salvador, Brazil.; Hospital São Rafael, Salvador, Brazil.
Milan EP; Universidade Federal do Rio Grande do Norte - UFRN, Natal, Brazil.
Pittella A; Hospital Quinta D'Or, Rio de Janeiro, Brazil.; Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil.; Universidade Unigranrio, Rio de Janeiro, Brazil.
Schwarzbold AV; Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil.
Sprinz E; Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Bonsall D; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Fraser C; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Fuskova M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Gilbert SC; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jenkin D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Kelly S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lambe T; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Simmonds P; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Golubchik T; Oxford Viral Sequencing Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. merryn.voysey@paediatrics.ox.ac.uk.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Andrew.pollard@paediatrics.ox.ac.uk.
DB Label: Database : MEDLINE

원문보기: OA (Springer) Open Access (PubMed Central) OA (Nature) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

학술저널

issue: Lancet (London, England) [Lancet] 2021 Apr 10; Vol. 397 (10282), pp. 1351-1362. Date of Electronic Publication: 2021 Mar 30.
Author: Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Golubchik T; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ariani CV; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Angus B; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Blane B; COVID-19 Genomics UK, Department of Medicine, University of Cambridge, Cambridge, UK.
Bonsall D; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Cicconi P; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Charlton S; National Infection Service, Public Health England, Salisbury, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Cox T; UK Biocentre, Milton Keynes, UK.
Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Douglas AD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK.
Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Flaxman AL; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Finn A; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Fuskova M; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Galiza E; St George's Vaccine Institute, St George's, University of London, London, UK.
Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
Green CM; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.
Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Hallis B; National Infection Service, Public Health England, Salisbury, UK.
Heath PT; St George's Vaccine Institute, St George's, University of London, London, UK.
Hay J; University of Glasgow, Glasgow, UK; Lighthouse Laboratory in Glasgow, Queen Elizabeth University Hospital, Glasgow, UK.
Hill HC; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lazarus R; Severn Pathology, North Bristol NHS Trust, Bristol, UK.
Libri V; NIHR UCLH Clinical Research Facility, London, UK; NIHR UCLH Biomedical Research Centre, London, UK.
Lillie PJ; Hull University Teaching Hospitals NHS Trust, Hull, UK.
Ludden C; COVID-19 Genomics UK, Department of Medicine, University of Cambridge, Cambridge, UK.
Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Minassian AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
McGregor AC; London Northwest University Healthcare, Harrow, UK.
Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Phillips DJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Pollock KM; NIHR Imperial Clinical Research Facility, London, UK; NIHR Imperial Biomedical Research Centre, London, UK.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Smith A; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital and School, University of Glasgow, Glasgow, UK.
Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Sutherland RK; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
Thomson EC; MRC University of Glasgow Centre for Virus Research, Glasgow, UK; Severn Pathology, North Bristol NHS Trust, Bristol, UK; Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK.
Toshner M; Heart Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK; NIHR Cambridge Clinical Research Facility, Cambridge, UK; Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK.
Turner DPJ; University of Nottingham, Nottingham, UK; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Vekemans J; AstraZeneca BioPharmaceuticals, Gaithersburg, MD, USA.
Villafana TL; AstraZeneca BioPharmaceuticals, Gaithersburg, MD, USA.
Williams CJ; Public Health Wales, Cardiff, UK; Aneurin Bevan University Health Board, Newport, UK.
Hill AVS; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Gilbert SC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

학술저널

issue: Lancet (London, England) [Lancet] 2021 Mar 06; Vol. 397 (10277), pp. 881-891. Date of Electronic Publication: 2021 Feb 19.
Author: Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Costa Clemens SA; Institute of Global Health, University of Siena, Siena, Italy; Department of Paediatrics, University of Oxford, Oxford, UK.
Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Weckx LY; Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.
Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Angus B; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Baillie VL; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Barnabas SL; Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa.
Bhorat QE; Soweto Clinical Trials Centre, Soweto, South Africa.
Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Briner C; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Cicconi P; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Cutland CL; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Dheda K; Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK.
Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK.
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Flaxman A; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Fairlie L; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Finn A; School of Population Health Sciences, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, UK.
Galiza E; St George's Vaccine Institute, St George's, University of London, London, UK.
Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
Green CM; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK.
Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Hill C; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Hill HC; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Hirsch I; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Izu A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Joe CCD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Koen A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Kwatra G; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
Lazarus R; Severn Pathology, North Bristol NHS Trust, Bristol, UK.
Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.
Lillie PJ; Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK.
Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Marshall RP; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Mendes AVA; Escola Bahiana de Medicina e Saúde Pública, Salvador, Braziland Hospital São Rafael, Salvador, Brazil; Instituto D'Or, Salvador, Brazil.
Milan EP; Universidade Federal do Rio Grande do Norte, Natal, Brazil.
Minassian AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
McGregor A; London Northwest University Healthcare, Harrow, UK.
Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Nana A; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Padayachee SD; Setshaba Research Centre, Pretoria, South Africa.
Phillips DJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Pittella A; Hospital Quinta D'Or, Rede D'Or, Rio De Janeiro, Brazil.
Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Pollock KM; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ritchie AJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Schwarzbold AV; Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil.
Smith A; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, UK.
Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Sprinz E; Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Sutherland RK; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
Thomson EC; MRC-University of Glasgow Centre for Virus Research & Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK.
Török ME; Department of Medicine, University of Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Toshner M; Heart Lung Research Institute, Dept of Medicine, University of Cambridge and NIHR Cambridge Clinical Research Facility, Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK.
Turner DPJ; University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.
Vekemans J; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Villafana TL; AstraZeneca BioPharmaceuticals, Cambridge, UK.
White T; AstraZeneca BioPharmaceuticals, Cambridge, UK.
Williams CJ; Public Health Wales, Cardiff, Wales; Aneurin Bevan University Health Board, Newport, Wales.
Douglas AD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Hill AVS; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Lambe T; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Gilbert SC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.

학술저널

issue: The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Feb; Vol. 21 (2), pp. e26-e35. Date of Electronic Publication: 2020 Oct 27.
Author: Hodgson SH; The Jenner Institute, University of Oxford, Oxford, UK. Electronic address: susanne.hodgson@ndm.ox.ac.uk.
Mansatta K; University of Oxford Clinical Medical School, Medical Sciences Division, University of Oxford, Oxford, UK.
Mallett G; University of Oxford Clinical Medical School, Medical Sciences Division, University of Oxford, Oxford, UK.
Harris V; Nuffield Department of Primary Care Health Sciences, Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Oxford, UK.
Emary KRW; Oxford Vaccine Group, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Pollard AJ; Oxford Vaccine Group, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 조회 - Impact Factor (JCR)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

학술저널